This presentation was delivered on behalf of the Central East Addiction Technology Transfer Center at the 2025 Virginia Specialty Dockets Annual Training on August 4, 2025.

This presentation identifies novel emerging drugs and the current data on their scope and severity in Virginia. It describes how these novel substances could impact drug court operations and summarizes opportunities to improve court practices.

This presentation was delivered on behalf of the Central East Addiction Transfer Technology Center, Mental Health Technology Transfer Center, and Prevention Technology Transfer Center at the 2021 Maryland Rural Health Conference on October 19, 2021.

This presentation summarizes the substance use issues facing rural counties in Maryland and the challenges to delivering services in rural areas. It describes the importance of strategic planning and strategies for identifying evidence-based services relevant to rural communities.

This presentation was delivered in conjunction with the Education Development Center at the Integrating Primary and Behavioral Health Care Through the Lens of Prevention Conference on November 15, 2018, in Fort Worth, Texas.

This presentation describes the changing nature of substance use prevention and the shifting health care landscape. It identifies health care payers, payment vehicles, & service delivery models and summarizes the implications of health care financing for prevention partnerships at both the individual and population health levels.

This presentation was delivered in conjunction with the Education Development Center at the 2018 National Prevention Network Conference on August 28, 2018, in Boston, Massachusetts.

This presentation describes national emerging drug trends involving prescription opioids, heroin, fentanyl, cocaine, methamphetamine, and marijuana. It also summarizes the role of substance use prevention in each of the three stages of a drug epidemic.

This presentation was delivered in conjunction with the Education Development Center at the 2018 National Prevention Network Conference on August 28, 2018, in Boston, Massachusetts.

This presentation summarizes marijuana laws at the state and local levels and the implications of marijuana legalization for substance use prevention professionals. It also reviews the pros and cons of the regulatory options available to states and considers the differences between the tobacco and alcohol models of for-profit regulation.

This presentation was delivered by Carnevale Associates at Utah Valley University’s 2013 Mental Health Symposium on February 22, 2013, in Orem, Utah.

This presentation examines the non-medical use of prescription drugs and the Office of National Drug Control Policy (ONCDP) strategies to curtail prescription drug misuse, notably examining prescription drug monitoring programs (PDMPs) and the Drug Enforcement Administration’s (DEA) proposed rule governing prescription drug takeback programs.

This presentation was delivered on behalf of the Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Substance Abuse Prevention (CSAP) under the Data Analysis Coordination and Consolidation Center (DACCC) at the 2011 National Prevention Network Conference on September 22, 2011, in Atlanta, Georgia.

This presentation explores ways to leverage valuable local indicator data from prescription drug monitoring programs (PDMPs) to inform substance abuse prevention policy and decision making.